19 research outputs found
Protein expression following 6 weeks of PGC-1Ξ± over-expression.
<p>Slow genes are shown in black (utrophin β A, slow myosin heavy chain β B) oxidative genes are shown in gray (cytochrome C β C, uncoupling protein-1 β D, complex IV subunit IV β E, myoglobin β F, Hsp 60 β G), pathway genes are shown in white (Sirt-1 β H, nuclear respiratory factor -1 β I, p38 β J, phospho-p38 β K), and controls have diagonal lines (Actin β L, Troponin β M, Spectrin β N). Relative change compared to control limbs (nβ=β6/group) (O). * indicates p<0.05 compared to control limbs.</p
Muscle and body mass following eight weeks of 100 mg/kg resveratrol feeding.
<p>*indicates significantly different from control. Nβ=β8/group. EDL - extensor digitorum longus, Rel β relative, TA β tibialis anterior, Gastroc β gastrocnemius.</p
PGC-1Ξ± induced changes in muscle function.
<p>Following four (nβ=β7) or six (sol nβ=β6; EDL nβ=β13) weeks of PGC-1Ξ± over-expression muscle function in the soleus and EDL was altered.</p><p>*indicates significantly different from corresponding control. Wk β week, sol β soleus, EDL β extensor digitorum longus, CSA β cross sectional area.</p
PGC-1Ξ± over-expression reduces disease-related muscle injury.
<p>10Γ micrographs of six week old soleus muscles following H and E staining (A and B). (C) The total areas of necrotic, H&E negative, or regenerating cells were quantified and is expressed as a percent of the total soleus area. In addition, laminin was detected with a fluorescently labeled antibody (not shown) in order to determine central nucleation. (D) PGC-1Ξ± caused a reduction in central nucleation. Nβ=β5/group; * indicates p<0.05.</p
Resveratrol supplementation increased fatigue resistance in dystrophic skeletal muscle.
<p>One month old mdx mice were fed a diet containing 100 mg/kg/day resveratrol or control diet for eight weeks. Resveratrol feeding increased fatigue resistance in the soleus (A) and force generated during the final contraction (B ) was higher in treated animals when compared to control. nβ=β8 Con; nβ=β6 Res; * indicates p<0.05.</p
Virally-mediated gene transfer.
<p>Six weeks following PGC-1Ξ± gene delivery total (PGC-1Ξ±) and viral (V-PGC-1Ξ±) expression was increased in treated limbs compared to untreated limbs (nβ=β6/group). * indicates p<0.05.</p
PGC-1Ξ± protects against muscle fatigue.
<p>Muscle fatigue curves in the soleus (nβ=β6/group) and EDL (nβ=β7/group) (A) during 10 minutes of a fatigue protocol where muscles are contracted every second for 10 minutes. Force of the final contraction (B) was significantly higher in the soleus and EDL muscles over-expressing PGC-1Ξ± when compared to control muscle. * indicates p<0.05.</p
PGC-1Ξ± induced changes in muscle mass.
<p>Following four (nβ=β7) or six (nβ=β13) weeks of PGC-1Ξ± over-expression in mdx mice muscle mass was generally reduced.</p><p>*indicates significantly different from corresponding control. EDL β extensor digitorum longus, Gastroc β gastrocnemius, TA β tibialis anterior.</p
Resveratrol supplementation did not improve resistance to contraction induced injury.
<p>Feeding a diet containing 100 mg/kg/day resveratrol for eight weeks did not improve resistance to contraction induced injury in (A) the EDL (nβ=β8 Con; nβ=β6 Res) or (B) the soleus (nβ=β8/group) when compared to control.</p
PGC-1Ξ± partially maintains diaphragmatic function six months following gene transfer.
<p>Neonatal mdx mice were injected in the sub-xyphiod region in order to cause diaphragmatic infection and sacrificed 6 mo later. Diaphragms over-expressing PGC-1Ξ± were more resistant to contraction induced injury (nβ=β4 Con; nβ=β7 PGC-1Ξ±) (A; Contraction 4 β pβ=β0.08), however, fatigue resistance was similar between groups (nβ=β7/group) (B). * indicates p<0.05.</p